An interventional study of POP surgery adjunctive PRP and POP surgery adjunctive with placebo ( NaCl Injection) in Pelvic Organ Prolapse Vaginal Surgery, Pelvic Organ Prolapse and Platelet Rich Plasma Injection, sponsored by Andalas University. Completed at 1 site in Indonesia. Open to female participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-08-10.
Sponsored by Andalas University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Pelvic organ prolapse (POP) is a common pelvic floor disorder associated with impaired quality of life and considerable postoperative recurrence following native tissue repair. Platelet-rich plasma (PRP) has emerged as a regenerative adjunct to improve tissue healing and surgical outcomes.
Objective: To evaluate the effect of adjuvant PRP on pelvic floor muscle A single-blind randomized controlled trial was conducted involving 40 women with stage II or higher POP who were randomly assigned to surgery with adjuvant PRP (n=20) or surgery alone (n=20). Pelvic floor muscle strength was assessed by perineometry, while anatomical outcomes were evaluated using the Pelvic Organ Prolapse Quantification (POP-Q) system 8 weeks postoperatively.
522 studies on the registry are indexed under Pelvic Organ Prolapse; 81 are open to participants now.
This study's enrollment of 40 is below the median of 80 across 337 interventional studies indexed under Pelvic Organ Prolapse.
Browse Pelvic Organ Prolapse studies →Andalas University is the lead sponsor of 7 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria: women aged ≤65 years with stage II or higher pelvic organ prolapse (POP) who provided written to participate
Exclusion Criteria:a history of gynecologic , collagen vascular disease, hematological disorders, or diabetes mellitus.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in the intervention group underwent standard prolapse surgery with adjuvant platelet-rich plasma administration. The control group underwent identical surgical treatment without PRP. A five 5 ml PRP injection is injected in 1,5 cm below urethra in pubocervicalis fascia in anterior vaginal wall following POP surgery in intervention group. Meanwhile 5 ml NaCl injection were injected in the same location following POP surgery in control group
Procedure: POP surgery adjunctive PRP
in this arm patient who received standard operation procedure was given placebo injection
Procedure: POP surgery adjunctive with placebo ( NaCl Injection)
In this RCT participants receive POP surgery with adjunctive PRP injection in anterior vaginal wall approximately 1,5 cm below urethra at Pubocervical Fascia. Pelvic organ prolapse quantification and assessment of Levator ani muscle tone by using Eden Q biofeedback tool before surgery and 8 weeks postoperative
During POP surgery placebo group receive NaCl injection in Pubocervicalis Fascia at 1,5 cm below urethra
Pelvic Floor Muscle Strength
Pelvic Floor Muscle strength was assessed by using EDAN q biofeedback. The output were resting tone, quick contraction, contonous contraction and post resting tone.
Time frame: From enrollment until post operative evaluation at 8 weeks
Degree of Pelvic Organ Prolapse
Degree of POP is measured by using POPQ assessment. Points Ba, C, and Bp are described degree of cystocele, uterine prolapse and rectocele respectively
Time frame: From enrollment to the post operative follow up at 8 weeks
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Aug 2025 to primary completion in Mar 2026, 7 months.
Of 162 non-industry interventional studies with no phase under Pelvic Organ Prolapse, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 43. This study's 7 months is below that.
Counting every sponsor, half of 179 studies reached it within 23 months; a quarter within 12 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Andalas University